GILD
Gilead Sciences, Inc.
NasdaqGS · USD · Stock
$170.68
+19.40 (+12.82%)
past month
Closed- Market cap
- $211.7B
- Yield
- 1.92%
- Volume
- 11.4M
- 52 weeks
- $117 – $176
About
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Gilead Sciences, Inc. (GILD) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $116.88 and $175.65, and it pays a dividend every quarter.
- Healthcare
- Drug Manufacturers - General
- Foster City, United States
- 17K employees
- Led by Daniel Patrick O'Day
Coming up
Ex-dividend
$0.82 per share last time
Financials
Revenue, last 12 months
$30.99B+6.80%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+2.82%
Q1 2026
+6.24%
Q2 2026
+6.86%
Q3 2026
+16.23%
Earnings per share, last 12 months -$3.13
Analysts
26 analysts say
Buy
12-month target$170.88+0.12%
Dividends
Yield · per share, yearly
1.92%$3.28
Ownership
- Institutions
- 92.01%
- Insiders
- 0.11%
Latest insider trade Sep 22, 2026, BURKHART ERIN
Prices from Yahoo Finance, may be delayed